Key facts
- This page summarizes Robert Eugene Watson's Form 4 filing for CEL SCI CORP (CVM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Jun 2022, 17:30.
Robert Eugene Watson - 13 Jun 2022 Form 4 Insider Report for CEL SCI CORP (CVM)
- Reporting relationship
- Director
- Issuer ticker
- CVM
- Reported as of
- 13 Jun 2022
- Net transaction value
- +$640
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2022, 17:30:44 UTC
- Prior SEC filing
- 07 Jul 2021
- Next SEC filing
- 10 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- Robert Watson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Eugene Watson filed Form 4 for CEL SCI CORP (CVM) on 14 Jun 2022.
Change
- Previous filing in this sequence was filed on 07 Jul 2021.
- Current net transaction value: +$640.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVM
transaction
Derivative
Options
Award
- Transaction value
- $640
- Shares
- +64,000
- Change %
- +13%
- Price
- $0.0100*
- Shares after
- 570,000
- Date
- 13 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,000
- Exercise price
- $3.35
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock options vest in three (3) equal annual installments commencing one year after the grant date.